SLC10A2 and fatty liver disease: Nevertheless, the reduction in hepatic steatosis and fibrosis in groups treated with P. niruri extract and metformin is associated with an effective reduction in the hepatic mRNA of PPARγ, SLC10A2, and Coll α1.